Risk factors of infective endocarditis-associated acute kidney injury: benefits of low-dose amikacin and surgery

感染性心内膜炎相关急性肾损伤的危险因素:低剂量阿米卡星和手术的益处

阅读:1

Abstract

OBJECTIVE: Acute kidney injury (AKI) is a frequent presentation in patients with infective endocarditis (IE), and is associated with poor outcomes. The primary aim of the study was to determine the risk factors for AKI in patients with IE. METHODS: A retrospective study was conducted in a tertiary hospital in China from August 2012 to April 2022. The primary outcome was AKI. Logistic regression was used to identify risk factors for AKI. RESULTS: A total of 594 patients with IE were included, of which 256 (43.1%) experienced AKI. The following variables were found to be independent risk factors for AKI: hypertension (OR 1.96, p = 0.011), Staphylococcus aureus infection (OR 2.69, p = 0.008), heart failure (OR 5.99, p < 0.001), shock (OR 5.93, p = 0.015) and hematuria (OR 2.38, p < 0.001). The use of low-dose amikacin (400 mg daily) was associated with a lower incidence of AKI (OR 0.38, p < 0.001). Among patients with IE complicated by heart failure, surgery was associated with a lower incidence of AKI (OR 0.21, p = 0.010). CONCLUSION: AKI is common in IE. Hypertension, Staphylococcus aureus infection, heart failure, shock and hematuria are risk factors of IE-associated AKI, whereas low-dose amikacin is a protective factor. Surgery is a protective factor of AKI in the setting of IE complicated by heart failure.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。